eNauka - pregled

Pregled prema Projekat Zentalis Pharmaceuticals

Prikaz rezultata 1 do 1 od 1
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2021565Tip A phase I/II dose-escalation and expansion study of ZN-c5, an oral selective estrogen receptor degrader (SERD), as monotherapy and in combination with palbociclib in patients with advanced estrogen receptor (ER)+/HER2-breast cancerAbramson, V; ...; Andric, Zoran G  ; Milovic-Kovacevic, Marijana M  ; Trifunovic, Jasna D; ...; (broj, koautora 16)Konferencijski rad
Mp kategorija će biti prikazana naknadno.